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Recent advances in metabolic engineering have demonstrated that
microbial biosynthesis can provide a viable alternative to chemical
synthesis for the production of bulk and ﬁne chemicals. Introduction
of a new biosynthetic pathway typically requires the expression of
multiple heterologous enzymes in the production host, which can
impose stress on the host cell and, thereby, limit performance of the
pathway. Unfortunately, analysis and treatment of the host stress
response can be difﬁcult, because there are many sources of stress
that may interact in complex ways. We use a systems biological
approach to analyze the stress imposed by expressing different
enzyme variants from a lineage of soluble P450 monooxygenases,
previously evolved for heterologous activity in Saccharomyces cer-
evisiae. Our analysis identiﬁes patterns of stress imposed on the
host by heterologous enzyme overexpression that are consistent
across the evolutionary lineage, ultimately implicating heme deple-
tion as the major stress. We show that the monooxygenase evolu-
tion, starting from conditions of either high or low stress, caused the
cellular stress to converge to a common level. Overexpression of
rate-limiting enzymes in the endogenous heme biosynthetic path-
way alleviates the stress imposed by expression of the P450 mono-
oxygenases and increases the enzymatic activity of theﬁnal evolved
P450 by an additional 2.3-fold. Heme overexpression also increases
the total activity of an endogenous cytosolic heme-containing cata-
lase but not a heterologous P450 that is membrane-associated. This
work demonstrates the utility of combining systems and synthetic
biology to analyze and optimize heterologous enzyme expression.
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The burgeoning ﬁeld of metabolic engineering offers the promiseof efﬁcient, controlled, scalable production of both ﬁne and bulk
chemicals (1–4). This approach is particularly important when
seeking to make complex molecules with deﬁned stereochemistry,
because such molecules are difﬁcult to synthesize chemically. For
example, plant secondary metabolites are a rich source of phar-
maceuticals but are difﬁcult to produce on an industrial scale. Total
chemical synthesis of complexmetabolites is prohibitively costly (5),
and extraction from plants can be unpredictable (6). Microbial
production of plant secondary metabolites offers a powerful alter-
native to traditional extraction methods (3). However, these bio-
synthetic pathways can be very complex and, therefore, require
simultaneous expression of many heterologous enzymes in the
production host. For example, the complete synthesis of morphine
from tyrosine requires a total of 14 separate enzymatic reactions (7).
These enzymes can potentially interact with each other andwith the
host cell in undesirable ways (8, 9), and the longer the biosynthetic
pathway the more opportunities arise for such interactions. Un-
derstanding and alleviating these harmful interactions can signiﬁ-
cantly improve the pathway productivity and yield (10, 11).
There are many different potential stresses resulting from
heterologous enzyme expression. These stresses range from the
predictable, including the common stresses attributable to het-
erologous protein production (12) and byproduct toxicity (13,
14), to the novel, such as the speciﬁc depletion of glycyl-tRNA in
strains of Escherichia coli that overexpress spider silk proteins (15).
Individually analyzing each source of stress would be a lengthy
process requiring an exhaustive and accurate list of potential stres-
sors. As an alternative to such a bottom-up approach, researchers
have used global analyses to measure the host’s response to the in-
duced stress, looking, for example, at changes in transcript (16) or
protein levels (17). These approaches offer an unbiased analysis of
the system and have the potential to discover unexpected sources of
stress. However, in many cases, a top-down analysis will identify too
many cellular responses. As a result, selecting the cause that is the
best target for treatment can still require either a lengthy search of
potential targets (10) or intuition regarding likely targets (18). In-
stead, inspiration can be taken from inverse metabolic engineering,
where researchers frequently compare multiple strains with varying
levels of productivity to identify the components responsible for the
observed variation in productivity (19–21). By analyzing multiple
enzyme or pathway variants, rather than only the ﬁnal optimized
strain, a search can quickly be narrowed to identify those select few
stress responses that show a consistent pattern across the entire set
of variants. Finally, once the sources of stress are identiﬁed, pathway
productivity can be increased by treating the key stressor, either by
eliminating the source of stress or by augmenting the host’s ability to
respond to the stress.
In this work, we consider the stress imposed by heterologous
overexpression of a P450 monooxygenase in Saccharomyces cer-
evisiae (Fig. 1 A and B). The yeast S. cerevisiae is a powerful plat-
form for the expression of a wide range of biosynthetic pathways,
particularly those involving membrane-bound proteins such as
eukaryal P450s (22). P450s are a major family of enzymes in plant
secondary metabolism, participating in the biosynthesis of metab-
olites ranging fromalkaloids and terpenoids to hormones and lipids
(23) and, as a result, are important heterologous targets for met-
abolic engineering. For example, the complete biosynthesis of hy-
drocortisone, taxol, or vincristine would require the heterologous
expression of four (24), eight (25), and at least three P450s (26),
respectively. However, although yeast is a good host for heter-
ologous P450 expression, achieving efﬁcient bioconversions using
native plant P450s is still challenging (27). This challenge has
motivated a search for more convenient alternatives, such as
adapting a tractable bacterial P450, CYP102A1, to catalyze the
desired reaction (28, 29).
The CYP102A1 variant used in this study had undergone
seven rounds of evolution in vivo, during which a synthetic RNA
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biosensor was used to screen for improvements in the enzyme’s
ability to demethylate caffeine to theophylline (29). As a result, we
have an entire lineage of enzyme mutants that exhibit a range of
enzyme activities and impose different levels of stress on the host
(Fig. 1 C and D). We performed a systems analysis on multiple
members of this lineage to track changes in the host’s response and,
thereby, identify a major cause of cellular stress. Our global anal-
ysis indicated that enzyme overexpression starves the cells for
heme, leading to a signiﬁcant change in the host physiology. Tar-
geted modiﬁcations increased the host’s heme biosynthetic ca-
pacity, raising the heme level by up to 60-fold and the product
concentration by 2.3-fold (Fig. 1E). These results demonstrate that
systems and synthetic biology can be successfully combined to in-
troduce and optimize a heterologous enzyme (29), analyze the
resulting stress imposed on the host, identify the most signiﬁcant
source of stress, and alleviate that source of stress to ultimately
increase the productivity of a biocatalytic process.
Results
Selection for Increased Enzymatic Activity at a Low Expression Level
Does Not Result in Increased Activity at High Expression. We pre-
viously evolved a caffeine demethylase (CDM) in vivo using a bio-
sensor based on a syntheticRNA switch (29). Through seven rounds
of mutagenesis and screening, we improved the enzymatic activity
by more than 30-fold. The caffeine demethylase underwent ﬁve
rounds of evolution while expressed from a high-copy 2μ plasmid to
yield the intermediate enzyme yCDM6.We then switched to a low-
copy centromeric plasmid and saw no change in product accumu-
lation. Two further rounds of evolution on a low-copy plasmid gave
our ﬁnal enzyme, yCDM8. However, when characterizing the set of
enzyme variants, we discovered anunexpected relationship between
the selection conditions and the enzyme performance. When we
moved the ﬁnal enzymes, yCDM7 and yCDM8, from low- to high-
copy plasmids, we found that they were only marginally more active
than yCDM6 expressed from a high-copy plasmid (Fig. 2). In con-
trast, the enzymes that were evolved onhigh-copy plasmids, yCDM2
through yCDM6, were equally active when expressed from high-
and low-copy plasmids. We hypothesized that the enzymes that
were identiﬁed on low-copy plasmids, yCDM7 and yCDM8, had
evolved to impose a stress on the cell that was tolerable when the
enzymewas expressedat low levels but deleteriouswhen the enzyme
expression level was increased.
Unfortunately, there are too many potential sources of stress
associated with heterologous P450 expression to exhaustively verify
each one. For example, the enzyme binds heme as a cofactor, se-
questering it fromother endogenous enzymes. Themonooxygenase
consumes NADPH and may produce toxic reaction byproducts.
The enzymemay beuncoupled, somany of the electrons taken from
the oxidation of NADPH are not transferred to the substrate but
instead produce reactive oxygen species (30). Additionally, the re-
laxed substrate selectivity of the monooxygenase might allow it to
oxidize endogenous compounds, consuming important metabolites
and producing potentially toxic byproducts. A careful character-
ization of each possible source of stress would be infeasible.
Microarray Analysis on a Lineage of Evolved P450s Identiﬁes Heme
Depletion As the Major Cellular Stress. Rather than individually
testing for each potential source of stress, we instead used DNA
microarrays to identify the source of the stress by analyzing the
global transcriptional response to monooxygenase overexpression.
We selected a total of eight strains for analysis: 1–6, yCDM1,
yCDM6, and yCDM8, each expressed from high- and low-copy
plasmids; 7, the catalytically inactive variant yCDM1-A264H (31)
expressed from a high-copy plasmid; and 8, an empty high-copy
plasmid. We then used principal component analysis (PCA) to
identify common patterns in expression across the different strains.
Although previous metabolic engineering analyses have treated
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Fig. 1. Systems analysis of multiple pathway variants can identify limiting
stresses. (A) A wild-type host cell has low stress. Circles, metabolites; poly-
gons, enzymes. (B) Addition of a heterologous pathway places a stress on
the host that limits growth and pathway productivity. (C and D) A systems
analysis of multiple enzyme or pathway variants (C) can identify consistent
patterns in gene expression that may indicate major sources of stress, such as
heme depletion (D). (E) Alleviating the stress improves the pathway pro-
ductivity, yielding a host and pathway that function well in combination
with each other.
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Fig. 2. Comparison of theophylline accumulation for high- and low-copy
enzyme expression. The early enzymes, through yCDM6, were identiﬁed
based on activity when expressed from a high-copy plasmid in yeast. The last
two enzymes, yCDM7 and yCDM8, were evolved on a low-copy plasmid
backbone. Cells containing each of the enzymes, either at high or low copy,
were grown in the presence of 1mMcaffeine. Theophylline accumulationwas
assayed in the supernatant after 24 h. The data are all normalized to yCDM1at
high copy (relative accumulation, 1.0). The error bars show ±1 SD, calculated
from three biological replicates, and the lines are a guide for the eye.
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the genes as variables and the samples as observations, applying
this analysis method to our data did not produce useful results.
Instead, we did the reverse, treating the samples as variables and
the genes as observations. This alternativemethod ofPCAhas been
applied to time-series data to identify patterns in expression over
time (32), and we used a similar approach to identify patterns over
evolutionary time. By analyzing the genes that are most strongly
associated with a given pattern of gene expression, we can identify
the speciﬁc source of stress that elicits the pattern. Ultimately, this
pattern can be interpreted as a measure of the magnitude of the
associated stress, because a stronger transcriptional response sug-
gests a greater level of stress.
The loadings for the ﬁrst principal component identiﬁed a pat-
tern of expression that explained ∼53% of the variability among
samples (Fig. 3). Next, the individual genes were given scores that
indicate how well the observed mRNA levels match this pattern of
expression (Fig S1A). We analyzed the genes with the highest
magnitude scores to identify transcription factors whose regulatory
targets were overrepresented in the subpopulation (33). These
transcription factors were likely involved in coordinating the stress
response, and the signals that they respond to are likely causes of
stress. The transcription factors identiﬁed in this analysis include
Rcs1, which responds to iron starvation, as well as Hap1 and
Rox1, which regulate genes in a heme-dependent manner. As
predicted, a closer look at several Rcs1-, Rox1-, and Hap1-de-
pendent genes shows a similar pattern to the loadings of the ﬁrst
principal component (Fig. S1B), suggesting that the loadings are
associated with the heme and iron levels, with lower values of the
loading correlating to lower intracellular levels of heme.
Increased Heme Biosynthesis Raises both the Intracellular Heme Level
and Monooxygenase Activity. Having implicated heme limitation
as the major source of cellular stress during heterologous over-
expression of the evolved P450 variants, we next sought to restore
the intracellular heme level to its native range. In bacteria, the ﬁrst
committed step in heme biosynthesis, producing δ-aminolevulinic
acid (ALA), is limiting and feeding additional ALA can increase
the expression of functional hemoproteins (34). However, ALA
synthesis is not a rate-limiting step in heme biosynthesis in yeast
(35). Therefore, to increase cellular heme levels, we tested a range
of conditions designed to increase ﬂux through the heme bio-
synthetic pathway (Fig. S2A): overexpression of a single rate-lim-
iting enzyme in heme biosynthesis, HEM3; overexpression of
HEM3 in combination with the next two rate-limiting enzymes,
HEM2 and HEM12; or overexpression of all three enzymes in
addition to feeding iron (II) and ALA.
We measured total cellular heme and porphyrin levels in yeast
with different levels of heme biosynthesis, using combinations of
gene overexpression and substrate feeding, and heme use, by
varying the P450 expression level. For a given level of heme use,
increasing the capacity of the heme biosynthetic pathway led to an
increase in the total heme concentration (Fig. S2B). However, we
only observed large increases in total heme content when heme
biosynthesis and use were both elevated (Fig. S2B). As expected,
increasing the capacity of the initial stages of heme biosynthesis led
to accumulation of biosynthetic intermediates (Fig. S2C). How-
ever, strong overexpression of a heme-containing enzyme led to
lower porphyrin levels, suggesting that the cell is actively control-
ling the conversion of porphyrins to heme, presumably by tran-
scriptional repression ofHEM13 in response to increasing levels of
free heme (36). When we measured HEM13 mRNA levels using
quantitative (q)RT-PCR, we found that HEM13 mRNA expres-
sion increased with increasing P450 expression levels and de-
creased below background levels when both heme and the P450
were highly expressed (Fig. S2D). These results are consistent with
our hypothesis that P450 overexpression starves the cell of free
heme but overexpression of the heme biosynthetic pathway can
restore the free heme level.
Heme Depletion Limits the Activity of Cytosolic Hemoproteins.Having
shown that increasing the cells’ capacity to produce heme leads to
an increase in the total heme level, we next considered the effect
this extra heme has on production of theophylline by the heter-
ologous P450. The effect of overexpressing heme biosynthesis is
not obvious: although our data suggest that heme is limiting in
cells that overexpress the P450 variants, total product accumu-
lation depends on a large number of factors. Heme is costly for
the cell to produce, and free heme is toxic to the cell. The beneﬁt
of alleviating the stress caused by heme limitation may be out-
weighed by the burden of producing the necessary heme.
We expressed the evolved P450 and the heme-overexpression
constructs from high-copy plasmids in S. cerevisiae and measured
enzymatic production of theophylline. When we increased the
host’s capacity to produce heme, we observed an increase in the
amount of theophylline produced, averaging a 2.3-fold improve-
ment at the optimal heme level (Fig. 4A). Unfortunately, the
experiments showed signiﬁcant day-to-day and culture-to-culture
variability, likely a result of varying copy numbers of the two plas-
mids. We also discovered that cells expressing both the P450 and
the heme-overexpression constructs grew more slowly than cells
with the enzyme and an empty plasmid (Fig. S3A). Given the stress
and variability associatedwith plasmid-based hemeoverexpression,
we next sought to optimize the heme-overexpression constructs to
minimize this stress. We integrated the heme-overexpression con-
structs into the yeast genome, eliminating the need to maintain
a high-copy plasmid while also presumably lowering the expression
of the genes. Unexpectedly, we found that cells with the integrated
copies of the overexpression constructs produced more heme than
cells with those same constructs on high-copy plasmids. The strain
with HEM2, HEM3, and HEM12 integrated simultaneously grew
very slowly (Fig. S3B) and produced more than 200 times as much
porphyrin (Fig. S3C). However, the strain with only HEM3 in-
tegrated exhibited no growth defect (Fig. S3B) and, in combination
with yCDM8 expressed from a high-copy plasmid, produced the
highest theophylline titers yet observed, reaching 42% conversion
(Fig. 4B). Notably, HEM3 overexpression had no effect on the-
ophylline production, either positive or negative, when yCDM8was
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Fig. 3. Microarray analysis identiﬁes heme depletion as the major cellular
stress. mRNA levels were measured in triplicate for cells containing different
enzyme variants, with either high or low expression. The mRNA expression
data were then analyzed using principal component analysis. The loadings
for the ﬁrst principal component are plotted for each of the six enzymes
assayed. The dashed black line denotes the loading for the no-enzyme
control. The black arrows show the evolutionary trajectory taken to identify
the enzymes. The error bars show ±1 SD, calculated from three biological
replicates, and the green and blue lines are a guide for the eye.
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expressed from a low-copy plasmid (Fig. 4B), demonstrating that
integratedHEM3 does not have an inherent deleterious effect and
that the beneﬁts of heme overexpression are dependent on the si-
multaneous overexpression of the hemoprotein yCDM8. As with
the plasmid-based heme-overexpression strategy, integrated ex-
pression of HEM3 also led to a decrease in the HEM13 mRNA
levels (Fig. S4A).
Finally, we examined whether the activity of other hemoproteins
was limited by heme biosynthesis. We tested two representative
enzymes: a cytosolic catalase, CTT1, and a membrane-associated
P450, yeast codon–optimized CYP2D6 (2). To test CYP2D6 ac-
tivity, we expressed both the P450 and heme biosynthetic gene(s)
from separate high-copy plasmids in a yeast strain with chromo-
somally integrated copies of three methyltransferases and a P450
reductase partner (CSY409; Table S1). We fed a substrate, nor-
laudanosoline, and measured accumulation of the product of the
P450, salutaridine (2). In contrast to the soluble CYP102A1 vari-
ant, CYP2D6 was not heme-limited and showed a slight decrease
in activity with increasing concentrations of heme (Fig. S5A). We
expect that CYP2D6 expression is limited instead by the ability of
the cell to accommodate large quantities of functional membrane
proteins (37). However, when we coexpressed the soluble catalase
CTT1with the heme biosynthetic genes, yeast cell lysates exhibited
nearly twice the catalase activity when the total heme level was
increased (Figs. S5B and S6). For comparison, previous work
overexpressing HEM2 alone led to a 40–60% increase in activity
from CTT1 (38). The differing responses of these two enzymes
demonstrate that our heme-overexpression strategy is neither
limited to the speciﬁc P450 we tested nor universally beneﬁcial to
hemoprotein expression.
Heme Depletion Limits Total Enzyme Expression. We next sought to
understand the mechanism underlying the observed increase in
enzyme activity as a result of increased heme levels. The increased
activity could plausibly be explained either by an increase in total
P450 expression or an increase in the speciﬁc activity of the en-
zyme. We previously demonstrated that total P450 expression was
roughly constant, irrespective of the enzyme variant or the plasmid
copy number (29). We hypothesized that most of the additional
proteins produced from the high-copy plasmid were misfolding,
leading to increased rates of protein degradation and equivalent
steady-state protein levels. When we measured the proteasomal
activity of cells expressing high or low levels of the ﬁnal enzyme
yCDM8, we found that cultures expressing yCDM8 from a high-
copy plasmid showed increased levels of proteasomal activity
compared with cells expressing the same enzyme from a low-copy
plasmid (Fig. 5A). However, when we increased the heme levels,
the proteasomal activity decreased to background levels (Fig. 5A)
and the total CDM expression increased (Fig. 5B). These results
suggest that the increase in total enzymatic activity that we ob-
served is attributable to increases in functional enzyme expression
rather than speciﬁc enzyme activity.
Discussion
In the past, systems biology has generally been applied to meta-
bolic engineering in two distinct fashions. When used in forward
metabolic engineering, researchers typically consider a single
strain and ask how that strain differs from a control. The difﬁculty
of using a global analysis lies in the sheer volume of data that can be
obtained. In one of our engineered strains, for example, the tran-
scription of 953 genes was signiﬁcantly different from the control
(P < 0.001), and greater than 20% of the genes measured showed
statistically signiﬁcant variation in at least one of the seven ex-
perimental strains. In this work, we adopted approaches from in-
verse metabolic engineering, where researchers examine multiple
improved variants to reverse engineer the causes of the improve-
ment and applied them to a forward engineering problem, to ra-
tionally optimize a system. By analyzing multiple closely related
enzyme variants, we were able to quickly narrow our focus to only
those genes that showed consistent patterns of expression across
these variants. This restricted set of genes then allowed us to
identify the transcription factors that were producing the co-
ordinated response and the ultimate source of stress. Although, in
hindsight, heme depletion is not an unexpected source of stress,
this was not the case at the beginning of the project. There were
many potential sources of stress, such as formaldehyde toxicity or
NADPH depletion, and heme depletion was, at most, only one of
several equally likely explanations.
Currently, any indirect analysis of this type is limited by the
assumption that cellular stress will be reﬂected in changes to the
levels of endogenous biomolecules, such as proteins or mRNA.
0%
5%
10%
15%
20%
25%
30%
35%
0 2 4 6 8 10
Relative Heme Content
Pe
rc
en
t C
on
ve
rs
io
n
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
yCDM8
High Copy
yCDM8
Low Copy
Pe
rc
en
t C
o
n
v
er
si
o n
WT
HEM3
BA
2.3x
Fig. 4. Increasing the total cellular heme level leads to an increase in total
enzymatic activity. (A) Cells expressing yCDM8 from a high-copy plasmid
were cotransformed with high-copy plasmids containing HEM3 or HEM2/3/
12. Cultures were grown in the presence of 1 mM caffeine and varying
amounts of iron and ALA. After 48 h, the theophylline concentration was
measured in the supernatant, and the cell pellets were assayed for heme
content. Each point represents the average of three biological replicates, and
error bars show ±1 SD. The data shown are concatenated from four separate
experiments to account for day-to-day variability. (B) Cells expressing yCDM8
from either a high- or low-copy plasmid were transformed into strains with
and without an integrated HEM3-expression construct. Strains were grown
and assayed as described above. Adding ALA to either the WT or HEM3
strains did not affect activity. The error bars show ±1 SD calculated from
three biological replicates.
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Fig. 5. Heme depletion leads to increased proteasomal activity and low
enzyme expression. (A) Proteasomal activity of strains expressing different
levels of yCDM8. Proteasomal activity was measured using a caged luciferin
that is released by the chymotrypsin-like activity of the yeast proteasome.
Luminescence is proportional to both the cell number and the speciﬁc pro-
teasomal activity. For each condition, three biological replicates were assayed
at each of three dilutions. The lines shown are a linear ﬁt to the data. For
yCDM8 expressed from a high-copy plasmid, overexpression of heme bio-
synthetic genes reduces the proteasomal activity. (B) Cells expressing yCDM8
from a high copy plasmid were cotransformed with a second heme-over-
expression plasmid. Cultures were grown to midlog phase and then assayed
for heme content and total P450 expression. Increased enzyme expression
correlates with increased heme accumulation. Each data point corresponds to
a single biological sample.
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When we observe changes in transcript levels, for example, we
can generally trust that they result from a disturbance to the host.
However, constant transcript levels can mean either that the
corresponding stress is absent or that the stress does not produce
a change in transcript levels. For example, our global analysis did
not identify protein degradation as a major host stress, even
though we later found that the proteasomal activity was signiﬁ-
cantly higher in some strains. This misidentiﬁcation is likely at-
tributable to posttranslational regulation of the proteasome (39,
40). Conversely, the P450 used in this work produces formaldehyde
as a byproduct, and, therefore, we identiﬁed formaldehyde toxicity
as one potential source of stress. The gene responsible for form-
aldehyde detoxiﬁcation, SFA1, is not differentially transcribed in
the strains that we analyzed. We could only rule out formaldehyde
toxicity by verifying in the literature that SFA1 would be induced
were formaldehyde present at high concentrations (41). Global
analyses would be more informative if we had a better method of
screening through these negative data to separate situations where
a lack of response is meaningful, such as SFA1, from those where
measuring transcript or protein levels does not inform us about the
underlying stress, as was the case for proteasomal activity.
Based on our global transcript analysis of a lineage of evolved
monooxygenases, we propose that the overexpression of a heme-
containingmonooxygenase depletes the intracellular pool of heme
and the resulting lack of heme places a stress on the cell that limits
the total enzymatic activity. High-copy expression of the enzyme
sequesters more heme and, therefore, produces a greater stress
than low-copy expression. Evolution of the enzyme at high copy
reduced the stress, suggesting that the stress imposed a selective
pressure to minimize the deleterious effects. However, decreasing
the enzyme DNA copy number removed both the stress of heme
depletion and the selective pressure to minimize that depletion.
Further evolution at low copy led to an increase in enzymatic ac-
tivity at low copy but also to greater heme use by the mono-
oxygenase. As a result, the enzymes that show improved activity at
low expression levels do not show corresponding increases in ac-
tivity at high expression levels.
Our results demonstrate that heme depletion has several effects
on yeast cells. First, lack of heme disrupts the host metabolism.
Without heme, the cells show gene expression proﬁles consistent
with anaerobic growth, despite the presence of sufﬁcient oxygen.
Second, low heme levels limit production of active P450 enzymes.
We propose that when heme levels are low, additional nascent
peptides are unable to properly bind heme and, as a result, misfold
and are subsequently degraded by the proteasome. Although our
results are consistent with this explanation, we cannot rule out an
alternate model in which increased proteasomal activity is not di-
rectly responsible for limiting P450 expression. In either case, the
combination of disrupted aerobiosis and the burden of recycling
misfolded protein (42) would reduce the host’s growth rate and
correspondingly reduce production of the desired compound. In
our system, increasing the heme supply, by chromosomally over-
expressing an endogenous rate-limiting biosynthetic enzyme, al-
leviated this source of stress and increased the total enzymatic
activity by 2.3-fold. In a system such as ours that is already highly
optimized, this level of improvement represents a signiﬁcant ad-
vance (21, 43).
The interplay between heme level, P450 expression, and ﬁnal
product titers is complicated. Focusing only on P450 expression,
we see only slight evidence of saturation after a ﬁvefold increase
in the heme level (Fig. 5B), suggesting that further increases to
the heme level could lead to still higher P450 expression. How-
ever, product titers reach a point of rapidly diminishing returns
after a ∼4-fold increase in the heme level (Fig. 4A), and the in-
crease in product titer (2.3-fold) is smaller than the increase in
P450 expression (∼3.8-fold), demonstrating either that enzyme
expression is no longer the limiting factor or that an increasing
fraction of the enzyme is functionally inactive. We conclude that,
in this system, a ∼fourfold increase in the heme level represents an
optimal balance between the burdens caused by increased heme
expression, P450 expression, and enzymatic activity. Therefore,
further optimization of the heme level by itself is unlikely to yield
signiﬁcant further improvements.
We have demonstrated that CYP102A1 is not the only enzyme
with heme-limited expression in yeast but also that not all hemo-
proteins are heme-limited. When expression of a soluble hemo-
protein is limiting, a similar heme-overexpression strategy may be
worthwhile. If optimal hemoprotein expression is required, our
heme-overexpression system could be improved by tuning the ex-
pression level of the HEM genes. Similarly, although feeding ALA
is a straightforward method for increasing precursor availability for
the heme biosynthetic pathway, the cost would be prohibitive on
an industrial scale, and overexpression of the ALA biosynthetic
pathway might be a preferable solution (44). Finally, this coupled
strategy of optimizing an enzyme and its host could be applied
iteratively, for example, by ﬁnding newly beneﬁcial enzyme muta-
tions that take advantage of the increased heme supply or identi-
fying the next limiting stress once the host has sufﬁcient heme.
We anticipate that the approaches described in this work will be
generally useful in the optimization of heterologous metabolic
pathways. The introduction of novel enzymes into a production
host can impose new sources of stress that the host is unable to
tolerate. Understanding and alleviating these sources of stress is an
important, and frequently unaddressed, challenge in enzyme and
pathway engineering. In addition to our speciﬁc solution, in which
heme overexpression leads to increased expression of a P450
monooxygenase, we propose that a systems analysis of multiple
variants of a heterologous pathway, when analyzed in the fashion
we have described, will generally provide additional insight into the
factors limiting pathway productivity and, therefore, enable further
pathway improvement. Such an analysis could study responses at
the transcript level, as in this example, or measure other factors,
such as protein expression or posttranslational modiﬁcations. Fi-
nally, after techniques from systems biology are used to identify the
key source of stress, methods from synthetic biology can be used to
alleviate the stress. Augmenting the host’s tolerance to stress, such
as by increasing the host’s ability to produce heme, requires careful
control to alleviate the existing source of stress without replacing it
with a new stressor. Toomuch heme can beworse than too little, for
example, and tools from synthetic biology will be particularly useful
for this type of delicate optimization. As metabolic engineers build
increasingly complex biosynthetic pathways, techniques to optimize
the host–pathway interface will become increasingly valuable.
Materials and Methods
Strains and Cultivation. The strains used in this work are derivatives of W303α
(MATα leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15). Transcription
analysis was conducted in CSY492 (W303 lys2::PTEF-GFP-L2Bulge8-ADH1T).
Cultures were grown in shake ﬂasks at 30 °C and 200 rpm in the appropriate
synthetic dropout media (Formedium) supplemented with 2% (wt/vol) glu-
cose, an additional 10 mg/L of adenine (Sigma-Aldrich), and 1 mM caffeine
(Sigma-Aldrich). Heme-overexpression strains were fed varying amounts of
iron (II) citrate and δ-aminolevulinic acid (Sigma-Aldrich). HEM-over-
expression constructs were integrated into the lys2 locus of W303. Assays for
salutaridine production were fed 4 mM norlaudanosoline (Santa Cruz Bio-
technology). Additional details on the plasmid construction process are
available in SI Materials and Methods.
Metabolite Analysis. Supernatant theophylline and salutaridine were sepa-
rated by liquid chromatography and assayed by UV-VIS spectroscopy (the-
ophylline) or MS (salutaridine) according to previously published protocols
(2). Additional details are available in SI Materials and Methods.
DNA Microarray Experiments. Details of the microarray experimental proce-
dures are available in SI Materials and Methods.
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Proteasomal Activity Measurements. Proteasomal activity was measured using
the Proteasome-Glo kit (Promega), according to the manufacturer’s direc-
tions. Details are available in SI Materials and Methods.
Heme Measurements. The intracellular heme concentration was measured
using a derivative of the protocol described by Sassa (45). Complete details
are included in SI Materials and Methods.
Quantitive Western Blots. Quantitative Western blots were performed as
described previously (29). Additional details are available in SI Materials
and Methods.
Catalase Activity Assays.A description of the catalase activity assay is available
in SI Materials and Methods.
qRT-PCR Measurements. qRT-PCRmeasurements were performed as described
previously (46). Additional details are available in SI Materials and Methods.
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